MEDIPAL HOLDINGS CORPMEDIPAL HOLDINGS CORPMEDIPAL HOLDINGS CORP

MEDIPAL HOLDINGS CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪454.74 B‬JPY
219.5JPY
‪41.48 B‬JPY
‪3.56 T‬JPY
‪169.73 M‬
Beta (1Y)
0.43
Employees (FY)
‪13.07 K‬
Change (1Y)
+280 +2.19%
Revenue / Employee (1Y)
‪1.80 M‬JPY
Net income / Employee (1Y)
‪20.96 K‬JPY

About MEDIPAL HOLDINGS CORP


CEO
Shuichi Watanabe
Headquarters
Tokyo
Founded
1898
ISIN
JP3268950007
FIGI
BBG000C3QKP9
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 7459 is 2,455.0 JPY — it has decreased by −0.30% in the past 24 hours. Watch MEDIPAL HOLDINGS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange MEDIPAL HOLDINGS CORP stocks are traded under the ticker 7459.
7459 stock has risen by 0.55% compared to the previous week, the month change is a −2.60% fall, over the last year MEDIPAL HOLDINGS CORP has showed a 6.14% increase.
We've gathered analysts' opinions on MEDIPAL HOLDINGS CORP future price: according to them, 7459 price has a max estimate of 2,800.00 JPY and a min estimate of 2,320.00 JPY. Watch 7459 chart and read a more detailed MEDIPAL HOLDINGS CORP stock forecast: see what analysts think of MEDIPAL HOLDINGS CORP and suggest that you do with its stocks.
7459 reached its all-time high on Jul 30, 2024 with the price of 2,770.0 JPY, and its all-time low was 440.0 JPY and was reached on Jan 25, 2002. View more price dynamics on 7459 chart.
See other stocks reaching their highest and lowest prices.
7459 stock is 2.20% volatile and has beta coefficient of 0.43. Track MEDIPAL HOLDINGS CORP stock price on the chart and check out the list of the most volatile stocks — is MEDIPAL HOLDINGS CORP there?
Today MEDIPAL HOLDINGS CORP has the market capitalization of ‪512.08 B‬, it has increased by 0.47% over the last week.
Yes, you can track MEDIPAL HOLDINGS CORP financials in yearly and quarterly reports right on TradingView.
MEDIPAL HOLDINGS CORP is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
7459 earnings for the last quarter are 60.98 JPY per share, whereas the estimation was 53.52 JPY resulting in a 13.94% surprise. The estimated earnings for the next quarter are 37.64 JPY per share. See more details about MEDIPAL HOLDINGS CORP earnings.
MEDIPAL HOLDINGS CORP revenue for the last quarter amounts to ‪915.36 B‬ JPY, despite the estimated figure of ‪912.63 B‬ JPY. In the next quarter, revenue is expected to reach ‪961.05 B‬ JPY.
7459 net income for the last quarter is ‪12.72 B‬ JPY, while the quarter before that showed ‪9.01 B‬ JPY of net income which accounts for 41.17% change. Track more MEDIPAL HOLDINGS CORP financial stats to get the full picture.
MEDIPAL HOLDINGS CORP dividend yield was 2.59% in 2023, and payout ratio reached 30.64%. The year before the numbers were 2.55% and 24.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪13.07 K‬ employees. See our rating of the largest employees — is MEDIPAL HOLDINGS CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPAL HOLDINGS CORP EBITDA is ‪74.46 B‬ JPY, and current EBITDA margin is 1.84%. See more stats in MEDIPAL HOLDINGS CORP financial statements.
Like other stocks, 7459 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPAL HOLDINGS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPAL HOLDINGS CORP technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPAL HOLDINGS CORP stock shows the buy signal. See more of MEDIPAL HOLDINGS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.